IM Cannabis Q1 Revenue Increases 18% Sequentially to $23.6 Million

IM Cannabis Reports Record First Quarter 2022 Financial Results; Revenues Increase 169% YoY to $23.6 Million. Gross Profit Increased 37% from Q1 2021 as Operational... #imcannabis #IMCHoldings #imcc

Related Keywords

Germany ,Jerusalem ,Israel General ,Israel ,United States ,Canada ,Quebec ,Toronto ,Ontario ,Israeli ,Canadian ,Vironna Pharm ,Oren Shuster ,Sde Avraham ,Adjupharm Gmbh ,Pharm Yarok ,Herbs Ltd ,Rosen High Way Ltd ,Israeli Medical Cannabis Agency ,Nasdaq ,Company Expects To Achieve Positive Adjusted ,Panaxia Labs Israel Ltd ,Nutraceuticals Inc ,International Financial Reporting Standards ,Im Cannabis Corp ,Acquisition Corp ,Ra Yarok Pharm Ltd ,Holdings Ltd ,Marketing Ltd ,Panaxia Pharmaceutical Industries Israel Ltd ,Trichome Financial Corp ,Panaxia Logistics Ltd ,Company Adjusted ,Ministry Of Agriculture ,Oranim Pharm Partnership ,Reports Record First Quarter ,Revenues Increase ,Profit Increased ,Operational Efficiencies ,Integration Take Hold ,Company Expects ,Achieve Positive Adjusted ,Chief Executive Officer ,Highland Grow ,Focus Medical Herbs ,Israeli Medical Cannabis ,Revoly Trading ,Rosen High Way ,Panaxia Pharmaceutical Industries Israel ,Panaxia Labs Israel ,Canada Dial In ,Focus Medical ,Trichome Financial ,Nova Scotia ,Forward Looking ,New Cannabis Ventures ,